Back

Breakthrough

Substack
breakingground.substack.com· irregular· Published 6 days ago

Breakthrough is a Substack newsletter by a medicine researcher that analyses frontier drug development, such as ESMO trial novelty rankings, 2026 first-in-class approvals, and first-in-human trials in China. It offers readers a structured, data-driven overview of where cutting-edge therapeutics are heading.

cancer researchclinical trialsfirst-in-class drugsesmoras inhibitorspharma pipelinechina biotechdrug approvalsmedical research analysis
Platform
Substack
Frequency
Irregular
Latest issue
Oct 21, 2026
Language
English
Written for
Clinicians, researchers, biotech investors and science-literate readers following cancer drug development
Tone
analytical
Tracked since
Oct 27, 2026

Website: https://breakingground.substack.com